An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Patients Undergoing Colon Resection
An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Patients Undergoing Colon Resection is a PHASE1 clinical asset sponsored by University of Minnesota in Recurrent Clostridioides Difficile Infection, Colonic Surgery. SEO and diligence focus: Orally administered preparation of fecal microbiota (MTP-101P), endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Indication: Recurrent Clostridioides Difficile Infection
Modality: small molecule
Target: Orally administered preparation of fecal microbiota (MTP-101P)
Sponsor: University of Minnesota
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 23, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Orally administered preparation of fecal microbiota (MTP-101P)
View original source fields
Condition raw: Recurrent Clostridioides Difficile Infection, Colonic Surgery
Condition normalized: Recurrent Clostridioides Difficile Infection, Colonic Surgery
Modality raw: small molecule
Modality normalized: small molecule
Target raw: Orally administered preparation of fecal microbiota (MTP-101P)
Target normalized: Orally administered preparation of fecal microbiota (MTP-101P)